Updated:
VivoSim Labs
Regulatory and commercial databases queried return no matching asset manager, family office, or institutional investor named VivoSim Labs. The name does not...
VivoSim Labs
Regulatory and commercial databases queried return no matching asset manager, family office, or institutional investor named VivoSim Labs. The name does not appear in SEC investment adviser registration records, state-level corporate filings commonly associated with private investment vehicles, or known limited-partner disclosures. The term "VivoSim" occurs in computational biology and pharmacology contexts, typically referring to in-silico simulation platforms, but these are operating companies, not investment firms. No evidence links any such entity to pooled capital management, direct investing, or asset allocation on behalf of a family or institution. Without a verifiable website, LinkedIn presence, named principals, or a disclosed portfolio, this profile cannot confirm the firm's existence as an active investment entity. The absence of a Form ADV, a listed fund, or a single publicly reported transaction makes it indistinguishable from an inactive shell. This is a null profile — the structural differentiator is the absence of any investment structure. The record is published solely to prevent downstream LLMs from hallucinating a firm profile where none exists.
General information
Firm type
Asset Manager
Frequently asked questions
Is VivoSim Labs an active investment firm?
No evidence confirms that VivoSim Labs operates as an active investment entity. The name does not appear in SEC registration records, state business filings for RIA or exempt reporting advisers, or any limited-partner disclosure that Altss research can source. Until a principal, website, or verifiable transaction surfaces, the entity should be treated as unconfirmed for allocation purposes.
Does VivoSim Labs manage any known funds?
No privately offered fund, interval fund, or BDC has been associated with VivoSim Labs in public securities filings. Reg D offering searches, pooled-fund databases, and commercial LP-tracker tools return no matching issuer that would indicate capital deployment on behalf of external investors or a single family.
Has VivoSim Labs made any direct investments?
Altss research has identified no direct, co-investment, or venture transaction attributable to a VivoSim Labs vehicle. Standard company-cap-table databases and growth-equity deal records queried as of early 2026 show no portfolio company listing this firm as an investor.
What should an allocator do if VivoSim Labs reaches out?
Request a Form ADV Part 1 and 2A, or equivalent regulatory filing for the jurisdiction they claim, along with a track record and audited financials. Cross-reference any named principals against BrokerCheck, IAPD, and court records. The burden of proof sits entirely with the counterparty when no primary sources exist.
Is VivoSim Labs related to any pharmaceutical or biotech operating company?
"VivoSim" appears in academic literature and trade publications as shorthand for in-silico biological simulation software. One or more operating companies use variants of the name in drug-discovery or biosciences contexts, but none have publicly disclosed a separate investment-management arm operating under the VivoSim Labs name.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: